Home > SWOT Analysis > Gilead Sciences (GILD) SWOT Analysis

Gilead Sciences (GILD) SWOT Analysis Profile

Gilead Sciences, Inc. develops and markets therapeutic medicines and processes for the treatment of life-threatening infectious diseases across the world, including biopharmaceuticals for the treatment of human immunodeficiency virus infection in adults; the treatment of chronic hepatitis B; the treatment of serious invasive fungal infections; the treatment of primary pulmonary hypertension and pulmonary hypertension; the treatment and prevention of influenza A and B; and the treatment of AIDS-related Kaposi�s sarcoma. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email

Free Email Newsletter

SWOT Conclusion

Strengths + Opportunities = 5

Threats + Weaknesses = 2

… A history of overcoming weaknesses makes it difficult for other firms to exploit their difficulties.